TABLE 2.

Cumulative reactogenicity for all SC602 trials at a 104-CFU dosea

SymptomSeverity104 CFU of SC602 (n = 58)Placebo (n = 16)
No. (%) with complaint95% CI (%)No. (%) with complaint95% CI (%)
Shigellosis00-500-17
Dysentery00-500-17
HeadacheMild or moderate21 (36)24-507 (44)20-70
Severe4 (7)2-1700-17
Abdominal crampsMild or moderate24 (41)29-556 (38)15-68
Severe2 (3)0.4-1200-17
Fever7 (12)5-231 (6)0.3-30
Diarrhea6 (10)4-211 (6)0.3-30
  • a Data are from this report and reference 3. Data are limited to the 2 weeks after vaccination. CI, confidence interval.